Related references
Note: Only part of the references are listed.IgG-like Bispecific Antibody CD3xEpCAM Generated by Split Intein Against Colorectal Cancer
Lei Wang et al.
FRONTIERS IN PHARMACOLOGY (2022)
CAR T cells in solid tumors: challenges and opportunities
Faroogh Marofi et al.
STEM CELL RESEARCH & THERAPY (2021)
Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors
Jim Middelburg et al.
CANCERS (2021)
Function of γδ T cells in tumor immunology and their application to cancer therapy
Jang Hyun Park et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2021)
Selective recruitment of γδ T cells by a bispecific antibody for the treatment of acute myeloid leukemia
Rajkumar Ganesan et al.
LEUKEMIA (2021)
Gamma Delta T Cells and Their Pathogenic Role in Psoriasis
Cong Qi et al.
FRONTIERS IN IMMUNOLOGY (2021)
The Mevalonate Pathway, a Metabolic Target in Cancer Therapy
Borja Guerra et al.
FRONTIERS IN ONCOLOGY (2021)
Costimulation of γδTCR and TLR7/8 promotes Vδ2 T-cell antitumor activity by modulating mTOR pathway and APC function
Huaishan Wang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Metabolic Changes in Tumor Microenvironment: How Could They Affect γδ T Cells Functions?
Anna Maria Corsale et al.
CELLS (2021)
Targeting butyrophilins for cancer immunotherapy
Marc Rigau et al.
TRENDS IN IMMUNOLOGY (2021)
Comprehensive analysis of BTN3A1 in cancers: mining of omics data and validation in patient samples and cellular models
Fan Liang et al.
FEBS OPEN BIO (2021)
Translating gammadelta (gamma delta) T cells and their receptors into cancer cell therapies
Zsolt Sebestyen et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells
Marc Rigau et al.
SCIENCE (2020)
Cancer immunotherapy with γδ T cells: many paths ahead of us
Dieter Kabelitz et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
Meir Rozenbaum et al.
FRONTIERS IN IMMUNOLOGY (2020)
Electroporation of NKG2D RNA CAR Improves Vγ9Vδ2 T Cell Responses against Human Solid Tumor Xenografts
Wei Xia Ang et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy
Ghita Chabab et al.
FRONTIERS IN IMMUNOLOGY (2020)
Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients
Mao Lin et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Heterogeneity of Human γδd T Cells and Their Role in Cancer Immunity
Hye Won Lee et al.
IMMUNE NETWORK (2020)
Broad Cytotoxic Targeting of Acute Myeloid Leukemia by Polyclonal Delta One T Cells
Biagio Di Lorenzo et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Allogenic V9V2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma
Mohammed Alnaggar et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Evaluating in vivo efficacy - toxicity profile of TEG001 in humanized mice xenografts against primary human AML disease and healthy hematopoietic cells
Inez Johanna et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Distribution and functions of T cells infiltrated in the ovarian cancer microenvironment
Xian Chen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Derivation of mimetic γδ T cells endowed with cancer recognition receptors from reprogrammed γδ T cell
Jieming Zeng et al.
PLOS ONE (2019)
Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
Yuxin Lin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Selena Vigano et al.
FRONTIERS IN IMMUNOLOGY (2019)
TCR Sequencing Reveals the Distinct Development of Fetal and Adult Human Vγ9Vδ2 T Cells
Maria Papadopoulou et al.
JOURNAL OF IMMUNOLOGY (2019)
PD-1 signaling modulates interferon-γ production by Gamma Delta (γδ) T-Cells in response to leukemia
Timm Hoeres et al.
ONCOIMMUNOLOGY (2019)
γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer
Bruno Silva-Santos et al.
NATURE REVIEWS CANCER (2019)
Tumor-associated macrophages: an accomplice in solid tumor progression
Yibing Chen et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Activation of PGE2/EP2 and PGE2/EP4 signaling pathways positively regulate the level of PD-1 in infiltrating CD8+ T cells in patients with lung cancer
Jinhong Wang et al.
ONCOLOGY LETTERS (2018)
The Generation of Human γδT Cell-Derived Induced Pluripotent Stem Cells from Whole Peripheral Blood Mononuclear Cell Culture
Daisuke Watanabe et al.
STEM CELLS TRANSLATIONAL MEDICINE (2018)
The potential role of gamma delta T cells after allogeneic HCT for leukemia
Rupert Handgretinger et al.
BLOOD (2018)
Memory T cells skew toward terminal differentiation in the CD8+T cell population in patients with acute myeloid leukemia
Ling Xu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Gamma-delta (γδ) T cells: friend or foe in cancer development?
Yijing Zhao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
gamma delta T cell responses: How many ligands will it take till we know?
David Vermijlen et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
The human Vδ2+ T-cell compartment comprises distinct innate-like Vγ9+ and adaptive Vγ9- subsets
Martin S. Davey et al.
NATURE COMMUNICATIONS (2018)
Molecular Determinants of Target Cell Recognition by Human γδ T Cells
Andre E. Simoes et al.
FRONTIERS IN IMMUNOLOGY (2018)
Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias
Vito Pistoia et al.
FRONTIERS IN IMMUNOLOGY (2018)
γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion
Elena Lo Presti et al.
FRONTIERS IN IMMUNOLOGY (2018)
Development and Selection of the Human Vγ9Vδ2+ T-Cell Repertoire
Carrie R. Willcox et al.
FRONTIERS IN IMMUNOLOGY (2018)
Defining Memory CD8 T Cell
Matthew D. Martin et al.
FRONTIERS IN IMMUNOLOGY (2018)
LAG3 (CD223) as a cancer immunotherapy target
Lawrence P. Andrews et al.
IMMUNOLOGICAL REVIEWS (2017)
Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor
Jonathan Fisher et al.
MOLECULAR THERAPY (2017)
Natural Killer T Cells in Cancer immunotherapy
Shiny Nair et al.
FRONTIERS IN IMMUNOLOGY (2017)
Butyrophilins: an important new element of resistance
Magdalena Malinowska et al.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2+ γδ T cell cytotoxicity in a perforin-dependent manner
Daniel W. Fowler et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation
Donnele Daley et al.
CELL (2016)
IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients
Rushikesh Sudam Patil et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Blinatumomab: a CD19/CD3 bispecific T cell engager (BiTE) with unique anti-tumor efficacy
Maria-Elisabeth Goebeler et al.
LEUKEMIA & LYMPHOMA (2016)
In vivo expansion and activation of T cells as immunotherapy for refractory neuroblastoma: A phase 1 study
Joseph G. Pressey et al.
MEDICINE (2016)
Analysis of tumor-infiltrating gamma delta T cells in rectal cancer
Liang Rong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity
Masato Muto et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Combined cellular immunotherapy and chemotherapy improves clinical outcome in patients with gastric carcinoma
Jiuwei Cui et al.
CYTOTHERAPY (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
The Role of Gamma Delta T Cells in Haematopoietic Stem Cell Transplantation
L. Minculescu et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2015)
Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against γδ T cell cytotoxicity
Daniel Gonnermann et al.
ONCOIMMUNOLOGY (2015)
Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma
Barbara Castella et al.
ONCOIMMUNOLOGY (2015)
Novel Bispecific Antibodies Increase γδ T-Cell Cytotoxicity against Pancreatic Cancer Cells
Hans-Heinrich Oberg et al.
CANCER RESEARCH (2014)
Dendritic Cell Cross Talk with Innate and Innate-like Effector Cells in Antitumor Immunity: Implications for DC Vaccination
Jasper J. P. van Beek et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2014)
γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
Pin Wu et al.
IMMUNITY (2014)
Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells
Martin Wilhelm et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
γδ T cell surveillance via CD1 molecules
Adrienne M. Luoma et al.
TRENDS IN IMMUNOLOGY (2014)
Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer
Ikuo Wada et al.
CANCER MEDICINE (2014)
The Feature of Distribution and Clonality of TCR γ/δ Subfamilies T Cells in Patients with B-Cell Non-Hodgkin Lymphoma
Liang Wang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Insights into vie relationship between toll like receptors and gamma delta T cell responses
Asif Amin Dar et al.
FRONTIERS IN IMMUNOLOGY (2014)
Clinical applications of gamma delta T cells with multivalent immunity
Drew C. Deniger et al.
FRONTIERS IN IMMUNOLOGY (2014)
Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain
Takamichi Izumi et al.
CYTOTHERAPY (2013)
Cutting Edge: CD1d Restriction and Th1/Th2/Th17 Cytokine Secretion by Human Vδ3 T Cells
Bozgana A. Mangan et al.
JOURNAL OF IMMUNOLOGY (2013)
Essential Requirements of Zoledronate-Induced Cytokine and gamma delta T Cell Proliferative Responses
Oliver Nussbaumer et al.
JOURNAL OF IMMUNOLOGY (2013)
Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor
Drew C. Deniger et al.
MOLECULAR THERAPY (2013)
Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells
Stefano Vavassori et al.
NATURE IMMUNOLOGY (2013)
Macrophages as potential targets for zoledronic acid outside the skeleton-evidence from in vitro and in vivo models
T. L. Rogers et al.
CELLULAR ONCOLOGY (2013)
Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells
Kelly Hudspeth et al.
FRONTIERS IN IMMUNOLOGY (2013)
The history of Toll-like receptors - redefining innate immunity
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa)
Lionel Couzi et al.
BLOOD (2012)
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells
Marta Coscia et al.
BLOOD (2012)
Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy
Daniel W. Fowler et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
William A. Freed-Pastor et al.
CELL (2012)
The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vδ1 TCR
Li Bai et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Tumor-promoting Versus Tumor-antagonizing Roles of γδ T Cells in Cancer Immunotherapy: Results From a Prospective Phase I/II Trial
Volker Kunzmann et al.
JOURNAL OF IMMUNOTHERAPY (2012)
The Multifunctionality of Human V?9Vd2?d T Cells: Clonal Plasticity or Distinct Subsets?
D. Kabelitz et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2012)
Redirecting αβT cells against cancer cells by transfer of a broadly tumor-reactive γδT-cell receptor
Victoria Marcu-Malina et al.
BLOOD (2011)
DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by γδ T lymphocytes
Oliver Nussbaumer et al.
BLOOD (2011)
Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
A. J. Nicol et al.
BRITISH JOURNAL OF CANCER (2011)
Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
Joshua M. Lang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Adoptive Immunotherapy for Advanced Non-small Cell Lung Cancer Using Zoledronate-expanded γδ T Cells: A Phase I Clinical Study
Miki Sakamoto et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
Makoto Kondo et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
Human γδ T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement
Amudhan Maniar et al.
BLOOD (2010)
The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia/lymphoma susceptibility to γδ T-cell cytotoxicity
Telma Lanca et al.
BLOOD (2010)
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients
S. Meraviglia et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells
Jun Nakajima et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2010)
γδ T cells promote the maturation of dendritic cells during West Nile virus infection
Hao Fang et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2010)
Generation of effector CD8+T cells and their conversion to memory T cells
Weiguo Cui et al.
IMMUNOLOGICAL REVIEWS (2010)
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway
Marta Coscia et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
Coculturing Dendritic Cells with Zoledronate Acid Efficiently Enhance the Anti-Tumor Effects of Cytokine-Induced Killer Cells
Xiaosan Su et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases
Christopher J. Chan et al.
JOURNAL OF IMMUNOLOGY (2010)
Effect of IL-18 on Expansion of γδ T Cells Stimulated by Zoledronate and IL-2
Wen Li et al.
JOURNAL OF IMMUNOTHERAPY (2010)
The NKG2D ligand ULBP4 binds to TCRγ9/δ2 and induces cytotoxicity to tumor cells through both TCRγδ and NKG2D
Yan Kong et al.
BLOOD (2009)
Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
Yu Abe et al.
EXPERIMENTAL HEMATOLOGY (2009)
Efficient Killing of Human Colon Cancer Stem Cells by gamma delta T Lymphocytes
Matilde Todaro et al.
JOURNAL OF IMMUNOLOGY (2009)
Early Triggering of Exclusive IFN-γ Responses of Human Vγ9Vδ2 T Cells by TLR-Activated Myeloid and Plasmacytoid Dendritic Cells
Marie-Claire Devilder et al.
JOURNAL OF IMMUNOLOGY (2009)
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Shawn D. Blackburn et al.
NATURE IMMUNOLOGY (2009)
Cross-presenting human γδ T cells induce robust CD8+ αβ T cell responses
Marlene Brandes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Toll-Like Receptor Expression and Function in Subsets of Human γδ T Lymphocytes
K. Pietschmann et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
IRAP Identifies an Endosomal Compartment Required for MHC Class I Cross-Presentation
Loredana Saveanu et al.
SCIENCE (2009)
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Zoledronate facilitates large-scale ex vivo expansion of functional gamma delta T cells from cancer patients for use in adoptive immunotherapy
M. Kondo et al.
CYTOTHERAPY (2008)
Bridging innate and adaptive immunity through γδ T-dendritic cell crosstalk
Emmanuel Scotet et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
V gamma 9V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs - Rituximab and trastuzumab
Hirotake Tokuyama et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma
Cecilia Melani et al.
CANCER RESEARCH (2007)
Large scale expansion of γ9δ2 T lymphocytes:: Innacell γδTM cell therapy product
Samuel Salot et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Tumor-infiltrating γδ T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway
Guangyong Peng et al.
IMMUNITY (2007)
Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short-term incubation with zoledronic acid
Francesca Fiore et al.
BLOOD (2007)
Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
Francesco Dieli et al.
CANCER RESEARCH (2007)
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing γδ T cell cytotoxicity
Angela Maerten et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Toll-like receptor 2 signaling modulates the functions of CD4+CD25+ regulatory T cells
HY Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Recognition of pollen-derived phosphatidylethanolamine by human CD1d-restricted γδ T cells
Anna M. Russano et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
TCRγδ+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRγδ+ T-cells
Y Sandberg et al.
LEUKEMIA (2006)
Toll-like receptor 2 controls expansion and function of regulatory T cells
RPM Sutmuller et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Human CD1-restricted T cell recognition of lipids from pollens
E Agea et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Professional antigen-presentation function by human γδ T cells
M Brandes et al.
SCIENCE (2005)
Homing and memory patterns of human γδ T cells in physiopathological situations
L Battistini et al.
MICROBES AND INFECTION (2005)
PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis
D Pende et al.
MOLECULAR IMMUNOLOGY (2005)
Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gamma delta T cells: role of CD86 and inflammatory cytokines
L Conti et al.
JOURNAL OF IMMUNOLOGY (2005)
Distinct subpopulations of γδ T cells are present in normal and tumor-bearing human liver
T Kenna et al.
CLINICAL IMMUNOLOGY (2004)
Polyinosinic-polycytidylic acid-mediated stimulation of human γδ T cells via CD11c+ dendritic cell-derived type I interferons
V Kunzmann et al.
IMMUNOLOGY (2004)
Differentiation of effector/memory Vδ2 T cells and migratory routes in lymph nodes or inflammatory sites
F Dieli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
γδ T cells for immune therapy of patients with lymphoid malignancies
M Wilhelm et al.
BLOOD (2003)
CD1-mediated γ/δ T cell maturation of dendritic cells
DS Leslie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis
HD Foda et al.
DRUG DISCOVERY TODAY (2001)
Share Paper
